{"_id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgN725ZAJDA","lastupdate":"2022-12-27T00:00:00.000Z","update_date":"2022-12-27T00:00:00.000Z","lastModified":"Sep 14, 2024","active":1,"confidence_score":100,"confidence_score_reason":"markets","urlname":"medinol","minimal_profile":null,"status":"","fullstatus":"","acquired":0,"hide_reason":null,"hide_reason_data":null,"hide_reasons":[{"id":"8257rxn4P8EFQOmS5hAAauHyYMhhxrA5u6yWX4XUShpybX3AMNo3Y9","reason":"Pending approval - External entity"},{"id":"aOIaOiiqfpA8UMw6VCTh8ueRmkG3lzDy1NGqEOaJbe11OrCzMTCCd6","reason":"The company is a service provider"},{"id":"ddgjKuc3GgH8E5UehSVJviRl471BCajL1plO8HtGoOojy2NivYqQ7x","reason":"Owner asked to delete"},{"id":"EjOKM211H1ira9J63oaGPuUxvr7Oba55TZo3NWsFO5uhbNu7o4x4zD","reason":"The company is not Israeli"},{"id":"J7fQJtnT3GdWWSE3MD8rzaW65LJ4jEIKxSZnneQiReONdZjG3zIqWe","reason":"Owner asked to hide in the meantime"},{"id":"NxlAC3ReFb5ksiYNLp2FnUyluoJzwRCYfcF7xpTZaPM53SdWQ5kv0B","reason":"Pending approval"},{"id":"RhC1tlwXzioK0MfzBII3H2wepEfQOfKVktmdwqeqTJjGi3ZaBWUqZo","reason":"The company is not innovative"},{"id":"S0Ed46vNI6vZYVxLedANWGjas23K6hY0QdsCtiGYL7lshqIEdLV3sA","reason":"The company ceased operations in Israel"},{"id":"VTANq7bEvlsEcPjp0ghelXfShaCosgndONGjgU730aAOxXtaDIF5j3","reason":"This is a product of an existing company"}],"type":"Startup","logokey":"$btb7Tf8FiFQtWWm3pptkJaP01ky6ENC6uZi0UrHkIY4FBt3MBWKdXk","name":"Medinol","oneliner":"Interventional Cardiology","registrar":"512622994","website":"https://medinol.com","careerspage":"http://medinol.com/careers","founded_month":12,"founded_year":1992,"formernames":[],"sociallinks":{"twitter":"https://twitter.com/medinol_stents","youtube":"https://www.youtube.com/channel/UC8sHKOicZo144WwtRQqmIDA/videos","facebook":"https://www.facebook.com/pages/Medinol/621377544539877","linkedin":"https://www.linkedin.com/company/145260","instagram":""},"social":["https://www.linkedin.com/company/145260","https://twitter.com/medinol_stents","https://www.facebook.com/pages/Medinol/621377544539877","https://www.youtube.com/channel/UC8sHKOicZo144WwtRQqmIDA/videos"],"flattenedsociallinks":"https://www.linkedin.com/company/145260|https://twitter.com/medinol_stents|https://www.facebook.com/pages/Medinol/621377544539877|https://www.youtube.com/channel/UC8sHKOicZo144WwtRQqmIDA/videos","apps":{"appstore":"","googleplay":""},"is_claimed_by_owner":1,"employees":"51-200","employees_exact":137,"patent":1,"raised":0,"stage":"Mature","public_stage":"Mature","primary_sector_key":"agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","primary_sector":"Health Tech & Life Sciences","alternativenames":[""],"about":"Medinol is dedicated to the science of cardiovascular intervention. Medinol develops, manufactures, and markets EluNIR, an elastomeric drug-eluting stent made from a thin cobalt-chrome alloy and recognized for its optimal balance between flexibility, conformability, scaffolding, and low metal footprint. EluNIR offers a new level of uniform drug elution and surface quality and demonstrated excellent clinical outcomes and long-term safety profile in clinical studies.\r\n\r\nEluNIR features the novel Flexx catheter technology with a visible metallic spring tip that eliminates tip flare-out and buckling. Flexx overcomes standard polymer tip limitations, offering both superb flexibility and uncompromised crossability, resulting in unprecedented ease of delivery even in complex anatomies.","climatetech_description":null,"is_climatetech_relevant":null,"phone":"+97237679000","country":null,"address":{"israeli":[{"id":"a974eaf4-8763-4732-b1c5-41ccaa4c23fc","city":"Jerusalem","type":null,"address":"Hartom Street 8, Jerusalem, Israel","placeid":null,"notactive":0,"openeddate":null,"registrarid":null,"firstrdcenter":0,"registrarname":null},{"id":"b0b088ba-59de-4739-b6df-9249404af108","city":"Tel Aviv-Yafo","type":null,"address":"Kiryat Atidim, Building 8 Tel Aviv-Yafo, Israel","placeid":null,"notactive":0,"openeddate":null,"registrarid":null,"firstrdcenter":0,"registrarname":null}],"officesabroad":[{"id":"3e1f8f66-029a-4249-88d7-26e2ab753bb4","city":"Colorado Springs","address":"13395 Voyager Pkwy, Colorado Springs, CO 80921, USA","country":"United States","placeid":null}]},"headquarter_address":null,"district":"Center District,Jerusalem District","news":[{"id":"ctV7DcRzVeugif2LRL7hvD0Y5mKgtuurb4Sv1ZyoLfM5wd4yc3snx3","date":"Sep 13, 2022","link":"https://www.prnewswire.com/il/news-releases/microtech-to-unveil-implantable-microsensor-technology-at-34th-transcatheter-cardiovascular-therapeutics-tct-annual-meeting-301621026.html","source":"www.prnewswire.com","visible":1,"analysis":{"tags":"MedTech, Implantable Microsensor","company":"Microtech, Medinol, Inc.","layoffs":"Not mentioned","summary":"Microtech, a subsidiary of Medinol, Inc., announced that its implantable microsensor platform will be presented at the 34th Transcatheter Cardiovascular Therapeutics (TCT). The platform is a new class of sensor technology that can be integrated onto any existing device, turning it into a smart, data-gathering device. The technology can be used for various medical conditions, providing wider healthcare access and reducing the need for office/hospital visits. The CEO of Medinol, Dr. Yoram Richter, will be presenting the technology platform.","partners":"Cardiovascular Research Foundation","customers":"Not mentioned","investors":"Not mentioned","confidence":9,"key_topics":["MedTech","Implantable Microsensor","Cardiovascular Treatment","Healthcare Access","Physiological Monitoring"],"date_of_event":"Friday, September 16","valuation_amount":"Not mentioned","impact_on_company":"growth-positive","investment_amount":"Not mentioned","structured_issues":["Customers","Partners"],"acquisition_amount":"Not mentioned","structuredIssuesShow":"#Customers  #Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"lzx38JDpaUOIPf5IiG3Q11iRJIfRVF9OKxuizv24rDlUWRqKPR9BSc","news_summary":"Microtech to unveil implantable microsensor technology at 34th Transcatheter Cardiovascular Therapeutics (TCT) annual meeting","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"7248f8c6-a289-4e8f-a2bd-0c7669d1e1f2","date":"Jan 6, 2020","link":"https://www.massdevice.com/medinol-stent-performs-just-as-well-as-medtronic-resolute-study-says/","source":"www.massdevice.com","visible":1,"analysis":{"tags":"medical devices","company":"Medinol","layoffs":null,"summary":"A clinical study shows that Medinols EluNIR drug-eluting stent performs just as well as Medtronics Resolute Integrity or Resolute Onyx stents. The study involved 2,221 people and compared the ridaforolimus-eluting stent from Medinol with the zotarolimus-eluting stent from Medtronic. Medinols EluNIR stent was approved by the FDA in 2017 and the first commercial implants took place in the U.S. in early 2018. The stent is distributed in the U.S. by Cardinal Healths Cordis business.","partners":["Medtronic","Cardinal Health"],"customers":null,"investors":null,"confidence":8,"key_topics":["Medinol stent","clinical study","EluNIR","Resolute Integrity","Resolute Onyx"],"date_of_event":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Partners","Customers"],"acquisition_amount":null,"structuredIssuesShow":"#Partners  #Customers","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"s1l1QvGMCiH4xK82YDRjewmoRzf9y5JuTseJ4JreOSf82THGdrxD9v","news_summary":"Medinol stent performs just as well as Medtronic Resolute, study says","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"e39e3da6-70b2-4285-a413-0cbf884215c9","date":"Jan 11, 2018","link":"https://www.cardiovascularbusiness.com/topics/coronary-intervention-surgery/cordis-and-medinol-announce-first-us-commercial-implants","source":"www.cardiovascularbusiness.com","visible":1,"analysis":{"tags":["medical","healthcare"],"company":"Cordis","layoffs":null,"summary":"Cordis, a Cardinal Health company, and Medinol have announced the first commercial cases using the EluNIR™ drug-eluting stent (DES) in the United States. The stent was approved for the treatment of patients with narrowing or blockages in their coronary arteries and is being distributed by Cordis. Cordis and Medinol have a long-term distribution agreement that gives Cordis the rights to sell Medinols coronary stent portfolio in the U.S. The EluNIR™ stent offers ease of delivery and is designed for use in highly complex cases. The first commercial cases were performed at New York-Presbyterian Hospital/Columbia University Medical Center and the Piedmont Heart Institute. Medinol has an extensive patent portfolio and is a leading developer in the cardiovascular intervention technology space.","partners":null,"customers":["New York-Presbyterian Hospital/Columbia University Medical Center","Piedmont Heart Institute"],"investors":null,"confidence":9,"key_topics":["EluNIR™ stent","drug-eluting stent","Cordis","Medinol","distribution agreement"],"date_of_event":"January 11, 2018","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Customers"],"acquisition_amount":null,"structuredIssuesShow":"#Customers","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"hQULu0Tug7M38H56Zb7rbw9VkwWeJoyuYVJE0wcTuZ7uXaLty8UPBL","news_summary":"Cordis and Medinol Announce First U.S. Commercial Implants of Innovative EluNIR™ Drug-Eluting Stent","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"ff51bf29-2513-4e53-b1bd-1365ec418557","date":"Dec 4, 2017","link":"http://www.globes.co.il/en/article-fda-approves-medinols-drug-coated-stent-1001214233","source":"www.globes.co.il","visible":1,"analysis":{"tags":"medical devices","company":"Medinol","layoffs":null,"summary":"Medinol, owned by Kobi and Judith Richter, has received FDA approval for its EluNIR drug-eluting stent. The stent is designed with a novel metallic spring tip and the narrowest strut width of any stent on the US market. Medinols new stent is expected to improve the companys competitiveness in the growing medicated stent market. Medinol was able to develop the stent after winning $750 million in damages from Boston Scientific in a lawsuit. The companys annual revenue is believed to be in the hundreds of millions of dollars. The EluNIR stent has demonstrated a low failure rate and zero percent rate of late stent thrombosis. This FDA approval marks the first for a privately held company based outside of the US.","partners":"Cordis, Cardinal Health","customers":null,"investors":null,"confidence":9,"key_topics":["Medinol","EluNIR stent","FDA approval","competition","medicated stents"],"date_of_event":"December 4, 2017","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Customers","Partners"],"acquisition_amount":null,"structuredIssuesShow":"#Customers  #Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"SFCqKdyuJdxrrxtae3o1ZJORn31SBEc7kT5WhmSCTjZ9yIglq8fbXp","news_summary":"FDA approves Medinol's medicated stent","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"975f6c05-43e9-4736-a5e5-389ce18505de","date":"Nov 30, 2017","link":"https://www.prnewswire.com/news-releases/cordis-and-medinol-announce-fda-approval-of-the-innovative-elunir-drug-eluting-stent-system-300564066.html","source":"www.prnewswire.com","visible":1,"analysis":{"tags":"FDA approval, coronary stent","company":"Cordis, a Cardinal Health company, and Medinol","layoffs":"N/A","summary":"Cordis, a Cardinal Health company, and Medinol have announced the FDA approval of the EluNIR drug-eluting stent (DES) for the treatment of patients with narrowing or blockages to their coronary arteries. The stent system is designed with a novel metallic spring tip and the narrowest strut width of any stent on the U.S. market. The EluNIR DES demonstrated outstanding efficacy and safety results in two randomized clinical trials. Cardinal Healths long-term distribution agreement with Medinol enables Cordis to sell Medinols coronary stent portfolio in the U.S.","partners":"Medinol","customers":"Patients with coronary artery disease","investors":"N/A","confidence":9,"key_topics":"FDA approval, EluNIR stent, coronary artery disease, partnership, market expansion","date_of_event":"Nov. 30, 2017","valuation_amount":"N/A","impact_on_company":"growth-positive","investment_amount":"N/A","structured_issues":"Partners, Customers","acquisition_amount":"N/A","structuredIssuesShow":"#Partners, Customers","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"F1ORAYCfLyetz6W4QhkSP9f2kA2zkNSYcMVsytJYehlkRfS6RL9MZ4","news_summary":"Cordis and Medinol Announce FDA Approval of the Innovative EluNIR Drug-Eluting Stent System","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"326acdad-e8a5-4e5c-8973-f0a302915b9a","date":"Oct 30, 2017","link":"https://www.medgadget.com/2017/10/elunir-drug-eluting-stent-from-medinol-wins-european-clearance.html","source":"www.medgadget.com","visible":1,"analysis":{"tags":"medical devices","company":"Medinol","layoffs":null,"summary":"Medinols EluNIR drug eluting stent has received CE Mark approval in Europe. The device is designed to prevent restenosis and has features such as a flexible tip and minimal metal material. The device showed outstanding results in clinical studies. Medinol is a medical device company based in Tel Aviv, Israel.","partners":null,"customers":null,"investors":null,"confidence":8,"key_topics":["EluNIR","drug eluting stent","CE Mark","ridaforolimus","flexibility"],"date_of_event":"October 30th, 2017","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Customers"],"acquisition_amount":null,"structuredIssuesShow":"#Customers","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"EPO4l8Lp9xOL2j7iSTJ2HMC8KxHZy6DFlaSRhAPbkoZqAXVENb2peN","news_summary":"EluNIR Drug-Eluting Coronary Stent from Medinol Wins European Clearance","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"f3b8071b-6a0f-4ae6-9cf1-47b35c7c18d5","date":"Aug 18, 2017","link":"https://www.healio.com/cardiac-vascular-intervention/percutaneous-coronary-intervention/news/online/%7B67634791-2ac6-4225-9f9f-d92920dca6ba%7D/ridaforolimus-eluting-stent-safe-effective-in-symptomatic-cad-treatment","source":"www.healio.com","visible":1,"analysis":{"tags":["medical devices"],"company":"Medinol Ltd.","layoffs":null,"summary":"A novel ridaforolimus-eluting stent developed by Medinol Ltd. was found to be noninferior to a zotarolimus-eluting stent in a clinical trial. The trial evaluated the safety and efficacy of the stent among patients with symptomatic CAD. The results showed that the new stent had similar outcomes to contemporary DES used in clinical practice. The trial was funded by Medinol Ltd. and the lead researcher, David E. Kandzari, has received consultant fees from various medical device companies. The article does not mention any specific customers or partners.","partners":null,"customers":null,"investors":null,"confidence":8,"key_topics":["stent","trial","safety","efficacy","patient population"],"date_of_event":"August 18, 2017","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Customers"],"acquisition_amount":null,"structuredIssuesShow":"#Customers","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"IvVDFPhBg4D6C0lXrKIK3e7KkMwNzz8YvCt3HqYiILwrQP0x3TMqub","news_summary":"Ridaforolimus-eluting stent safe, effective in symptomatic CAD treatment","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"}],"newsNumber":7,"events":null,"techcommunityinvolvement":null,"mediagallery":[{"id":"0e0f95ed-a8fa-432d-b7a5-91e19ea806d9","timestamp":"2020-11-09 14:30:24.000000","resources_type":2,"resources_title":"EluNIR eDES by Medinol","resources_file_name":"WPcxdOnYVM8","alt":"EluNIR eDES by Medinol logo","imageurl":"https://img.youtube.com/vi/WPcxdOnYVM8/0.jpg","url":"http://youtu.be/WPcxdOnYVM8"},{"id":"be5592df-bcde-4fd5-aa24-2a658154d248","timestamp":"2020-11-09 14:29:56.000000","resources_type":2,"resources_title":"The Making of EluNIR eDES","resources_file_name":"Wyz37ruI_rw","alt":"The Making of EluNIR eDES logo","imageurl":"https://img.youtube.com/vi/Wyz37ruI_rw/0.jpg","url":"http://youtu.be/Wyz37ruI_rw"}],"tags":["hospitals","drug-delivery","sustained-release","cardiology","medical-devices","surgery","stent","cardiovascular","polymers","catheters","alloys"],"classificationIDs":["agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfQhvYKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfeyIYIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1r_gKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfeyKYIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PvpvP8KDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZwKILDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety68JDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LvQvp4JDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA"],"technologysuccessstory":null,"usecases":[],"businessmodels":["B2B"],"productstage":"Released","products":["EluNIR","X-Suit NIR","eDES","ChampioNIR","NC Gallant","Gallant","NIRxcell","Assure"],"geomarkets":["Global"],"targetmarkets":[],"marketcapital":null,"marketcapitaldate":null,"funding":{"investors":0,"lastfunding":"Undisclosed","totalrounds":0,"fundingstage":"Mature","totalfunding":"Undisclosed","publicinvestors":0,"lastpublicfunding":null,"totalpublicrounds":0,"totalpublicfunding":0},"team":[{"name":"Yoram Richter","email":"yoram@medinol.com","phone":"","gender":"Male","userid":"MYi3ul5Bgo9QPjStxYkXmX0yDnLJjXXtEcCKIFRRFUu1TlyY1dNIWp","bounced":true,"claimed":null,"founder":0,"urlname":"yoram-richter","visible":1,"memberid":"HIg0Oz5mI9Vv7lupimtMkF8LT6fJuvOFnNMitIWvciumU6ctK66FLw","position":"CEO","last_name":"Richter","claimtoken":"wj6TO9iTvShZ3XuVuVYT5c3ELxkc1PHFYyGlO1LvWZxCz1a9qOfRM5","first_name":"Yoram","picturekey":null,"claimeddate":null,"linkedinurl":null,"unsubscribed":false,"is_activeuser":0,"additionalemail":"","claimedemaildate":"2022-12-27 17:42:51.000000","initials":"YR","pictureurl":"/assets/empty-state.svg","linkedin-display":"none","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Judith Richter","email":"judith.richter@medinol.com","phone":"","gender":"Female","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAgJ6-5ZYKDA","bounced":true,"claimed":0,"founder":1,"urlname":"judith-richter","visible":0,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgICAvrjAjwgM","position":"Co-founder & CEO","last_name":"Richter","claimtoken":"c1e6969ead53aad3b639ed9a4af629fbfa312a4c5daca4d5e9af9f24bd712b59","first_name":"Judith","picturekey":null,"claimeddate":null,"linkedinurl":null,"unsubscribed":false,"is_activeuser":0,"additionalemail":"judith@medinol.com","claimedemaildate":"2020-11-02 10:32:21.000000","initials":"JR","pictureurl":"/assets/empty-state.svg","linkedin-display":"none","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"private-visibility","visibilityTooltip":"tooltip tooltip-html-content='<style>\n    .visibility-tooltip-container {\n        display: flex;\n        column-gap: 0.8rem;\n        padding: 0.8rem 1rem;\n        align-items: center;\n    } \n\n    .visibility-tooltip-container text {\n        font-size: 1.4rem;\n        text-transform: capitalize;\n        font-weight: 500;\n    }\n</style>\n\n<div class=\"visibility-tooltip-container\">\n    <img height=\"20\" width=\"20\" style=\"display: flex\" src=\"/assets/private-visibility.svg\"/>\n    <img height=\"20\" width=\"20\" style=\"display: none\" src=\"/assets/internal-visibility.svg\"/>\n    <text>private</text>\n</div>'"},{"name":"Kobi Richter","email":"kobi.richter@medinol.com","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAgLGF-5AJDA","bounced":true,"claimed":0,"founder":1,"urlname":"kobi-richter-2","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgICA8dmNnwgM","position":"Co-founder ","last_name":"Richter","claimtoken":"2kaeRK2ejf9jcBwEn9YHoiHExw4MpdbDx00p1QrSI8T7YvJGumCtne","first_name":"Kobi","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/kobi-richter-058518a6/","unsubscribed":false,"is_activeuser":0,"additionalemail":"kobi@medinol.com","claimedemaildate":"2022-12-27 15:26:27.000000","initials":"KR","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Yulim ZINGERMAN","email":"yulim@medinol.com","phone":"","gender":"Male","userid":"bRUHSKjMUherUUXENFoLQgSTswpOL7wBQQ7PNuLZN46KaZy3RoQVDN","bounced":true,"claimed":null,"founder":0,"urlname":"yulim-zingerman-1","visible":1,"memberid":"WU3UhurjcJ4AzQVoNtYNr7YWyi3JBM2vVorl3Ok9dhZqbmjrkLpOmZ","position":"CTO","last_name":"ZINGERMAN","claimtoken":"pttheXMwzEeouljCMuRiKuPlkbif4rXvjG8FR3ivqJytWPO30i6rKi","first_name":"Yulim","picturekey":null,"claimeddate":null,"linkedinurl":null,"unsubscribed":false,"is_activeuser":0,"additionalemail":"","claimedemaildate":"2022-12-27 17:42:53.000000","initials":"YZ","pictureurl":"/assets/empty-state.svg","linkedin-display":"none","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Suzy Amrani","email":"suzy.amrani@medinol.com","phone":"","gender":"Female","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICA4JTOjpIKDA","bounced":true,"claimed":0,"founder":0,"urlname":"suzy-amrani","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgIDgxIj8iAkM","position":"HR Group Manager","last_name":"Amrani","claimtoken":"tohgbvUWqgSErga0XElKw47S5TXacxiqHXCUtAixWnKHKpm2EUUrE4","first_name":"Suzy","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/suzy-amrani-5593854/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2022-12-27 15:26:58.000000","initials":"SA","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Ravit  Kinamon","email":"ravitk@medinol.com","phone":"0524288410","gender":"Female","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICA4K2kvosKDA","bounced":false,"claimed":1,"founder":0,"urlname":"ravit-kinamon","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgIDg7ffh3AkM","position":"Marketing Communications Manager","last_name":"Kinamon","claimtoken":"a5cd6e3b47b0b5a6705c7af218d6a381833c12c666680e4fbc195fb726569b24","first_name":"Ravit ","picturekey":null,"claimeddate":"2020-11-09","linkedinurl":"https://www.linkedin.com/in/ravit-kinamon-3524921/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2020-11-09 13:40:44.000000","initials":"RK","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"","visibilityTooltip":""}],"description_edited":1,"tag_line_edited":1,"sector":"Digital Health and Medical Technologies","sectorverify":{"id":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAgLHD0KwIDA","fullname":"Sharon Shapira"},"biverify":{"id":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAgLHD0KwIDA","fullname":"Sharon Shapira"},"biverifydate":"2020-02-13T00:00:00.000Z","crunchbaseid":"Medinol","lastupdator":"Yanina Wainscheinker","lastupdator_email":"yanina.wainscheinker@sncentral.org","creator":"Tamar Weiss","creator_email":"tamar.e.weiss@gmail.com","createdate":"2014-07-24T00:00:00.000Z","biverification":"Sharon Shapira","sectorverification":"Sharon Shapira","affiliatedOrganizations":null,"timeline":[],"investmentstage":[],"exits":[],"investments":[],"portfolio":[],"funds":[],"founded":"12/1992","databases":[],"sharedspaces":[],"utilities":[],"contributors":[],"employeesworldwide":"","fundingtype":"Startup","parsedName":"Medinol","logourl":"https://storage.googleapis.com/clean-finder-353810/$btb7Tf8FiFQtWWm3pptkJaP01ky6ENC6uZi0UrHkIY4FBt3MBWKdXk","oglogourl":"https://storage.googleapis.com/clean-finder-353810/$btb7Tf8FiFQtWWm3pptkJaP01ky6ENC6uZi0UrHkIY4FBt3MBWKdXk","seoabout":"Medinol is dedicated to the science of cardiovascular intervention. Medinol develops, manufactures, and markets EluNIR, an elastomeric drug-eluting stent m...","seoTitle":"Israeli Startup","solutions":[],"teamMembersNumber":6,"primarySector":"Health Tech & Life Sciences","primary-sector-display":"block","classifications":[{"depth":0,"name":"Sector","queryString":"sectorclassification=undefined","classificationName":"sectorclassification"},{"depth":1,"name":"Health Tech & Life Sciences","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Pharma & Medical Biotechnology","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA","classificationName":"sectorclassification"},{"depth":3,"name":"Drug Delivery","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1r_gKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Medical Devices","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA","classificationName":"sectorclassification"},{"depth":3,"name":"Medical Treatment & Therapeutics","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfQhvYKDA","classificationName":"sectorclassification"},{"depth":0,"name":"Core Technology","queryString":"coretechnology=undefined","classificationName":"coretechnology"},{"depth":1,"name":"Materials & Substances","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfeyKYIDA","classificationName":"coretechnology"},{"depth":2,"name":"Alloys","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZwKILDA","classificationName":"coretechnology"},{"depth":2,"name":"Polymers","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety68JDA","classificationName":"coretechnology"},{"depth":0,"name":"Target Customer","queryString":"targetcustomer=undefined","classificationName":"targetcustomer"},{"depth":1,"name":"Healthcare & Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Healthcare","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","classificationName":"targetcustomer"},{"depth":3,"name":"Providers","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","classificationName":"targetcustomer"},{"depth":1,"name":"Commerce & Retail","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PvpvP8KDA","classificationName":"targetcustomer"},{"depth":2,"name":"Distribution Channels","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LvQvp4JDA","classificationName":"targetcustomer"},{"depth":3,"name":"Distributor","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfeyIYIDA","classificationName":"targetcustomer"}],"classificationDelimited":["SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Medical Devices#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA>Medical Treatment & Therapeutics#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfQhvYKDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","IndustryClassificationModel>Commerce & Retail#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PvpvP8KDA>Distribution Channels#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LvQvp4JDA>Distributor#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfeyIYIDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA>Drug Delivery#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1r_gKDA","TechnologyClassificationModel>Materials & Substances#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfeyKYIDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","IndustryClassificationModel>Commerce & Retail#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PvpvP8KDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA>Providers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","TechnologyClassificationModel>Materials & Substances#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfeyKYIDA>Alloys#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZwKILDA","TechnologyClassificationModel>Materials & Substances#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfeyKYIDA>Polymers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety68JDA","IndustryClassificationModel>Commerce & Retail#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PvpvP8KDA>Distribution Channels#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LvQvp4JDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Medical Devices#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA"],"classificationsViewModel":"|0:>SectorClassificationModel|1:>SectorClassificationModel/Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA|2:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA/Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA|3:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA/Drug Delivery#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1r_gKDA|2:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA/Medical Devices#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA|3:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Medical Devices#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA/Medical Treatment & Therapeutics#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfQhvYKDA|0:>IndustryClassificationModel|1:>IndustryClassificationModel/Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA|2:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA/Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA|3:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA/Providers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA|1:>IndustryClassificationModel/Commerce & Retail#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PvpvP8KDA|2:>IndustryClassificationModel>Commerce & Retail#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PvpvP8KDA/Distribution Channels#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LvQvp4JDA|3:>IndustryClassificationModel>Commerce & Retail#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PvpvP8KDA>Distribution Channels#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LvQvp4JDA/Distributor#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfeyIYIDA|0:>TechnologyClassificationModel|1:>TechnologyClassificationModel/Materials & Substances#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfeyKYIDA|2:>TechnologyClassificationModel>Materials & Substances#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfeyKYIDA/Alloys#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZwKILDA|2:>TechnologyClassificationModel>Materials & Substances#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfeyKYIDA/Polymers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety68JDA|","classificationTrees":{"sector":[{"title":"Health Tech & Life Sciences","key":"0-0","path":"SectorClassificationModel>Health Tech & Life Sciences","children":[{"title":"Pharma & Medical Biotechnology","key":"0-0-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Pharma & Medical Biotechnology","children":[{"title":"Drug Delivery","key":"0-0-0-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Pharma & Medical Biotechnology>Drug Delivery"}]},{"title":"Medical Devices","key":"0-0-1","path":"SectorClassificationModel>Health Tech & Life Sciences>Medical Devices","children":[{"title":"Medical Treatment & Therapeutics","key":"0-0-1-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Medical Devices>Medical Treatment & Therapeutics"}]}]}],"targetCustomer":[{"title":"Healthcare & Life Sciences","key":"0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences","children":[{"title":"Healthcare","key":"0-0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Healthcare","children":[{"title":"Providers","key":"0-0-0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Healthcare>Providers"}]}]},{"title":"Commerce & Retail","key":"0-1","path":"IndustryClassificationModel>Commerce & Retail","children":[{"title":"Distribution Channels","key":"0-1-0","path":"IndustryClassificationModel>Commerce & Retail>Distribution Channels","children":[{"title":"Distributor","key":"0-1-0-0","path":"IndustryClassificationModel>Commerce & Retail>Distribution Channels>Distributor"}]}]}],"coreTechnology":[{"title":"Materials & Substances","key":"0-0","path":"TechnologyClassificationModel>Materials & Substances","children":[{"title":"Alloys","key":"0-0-0","path":"TechnologyClassificationModel>Materials & Substances>Alloys"},{"title":"Polymers","key":"0-0-1","path":"TechnologyClassificationModel>Materials & Substances>Polymers"}]}]},"sectorClassifications":[{"depth":0,"name":"Sector","queryString":"sectorclassification=undefined","classificationName":"sectorclassification"},{"depth":1,"name":"Health Tech & Life Sciences","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Pharma & Medical Biotechnology","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA","classificationName":"sectorclassification"},{"depth":3,"name":"Drug Delivery","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1r_gKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Medical Devices","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA","classificationName":"sectorclassification"},{"depth":3,"name":"Medical Treatment & Therapeutics","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfQhvYKDA","classificationName":"sectorclassification"}],"coreTechnologyClassifications":[{"depth":0,"name":"Core Technology","queryString":"coretechnology=undefined","classificationName":"coretechnology"},{"depth":1,"name":"Materials & Substances","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfeyKYIDA","classificationName":"coretechnology"},{"depth":2,"name":"Alloys","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZwKILDA","classificationName":"coretechnology"},{"depth":2,"name":"Polymers","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety68JDA","classificationName":"coretechnology"}],"targetCustomerClassifications":[{"depth":0,"name":"Target Customer","queryString":"targetcustomer=undefined","classificationName":"targetcustomer"},{"depth":1,"name":"Healthcare & Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Healthcare","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","classificationName":"targetcustomer"},{"depth":3,"name":"Providers","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","classificationName":"targetcustomer"},{"depth":1,"name":"Commerce & Retail","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PvpvP8KDA","classificationName":"targetcustomer"},{"depth":2,"name":"Distribution Channels","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LvQvp4JDA","classificationName":"targetcustomer"},{"depth":3,"name":"Distributor","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfeyIYIDA","classificationName":"targetcustomer"}],"classificationNames":{"sector":["Health Tech & Life Sciences","Pharma & Medical Biotechnology","Drug Delivery","Medical Devices","Medical Treatment & Therapeutics"],"coreTechnology":["Materials & Substances","Alloys","Polymers"],"targetCustomer":["Healthcare & Life Sciences","Healthcare","Providers","Commerce & Retail","Distribution Channels","Distributor"]},"section":null,"sectionParams":"","queryParams":"","popup_claim_profile":"false","claimedBadge":"inline","display":{"mainContact":"none","climateTag":"none","seeMoreSimilarCompanisDisplay":"none","similarCompaniesTitleFontSize":"3.2rem","similarCompaniesTitle":"Similar Companies","similar_companies":[]},"mainContact":{},"_eventview":{"publicoffering_exit":[],"privateequityfunding":[],"nonequityfunding":[],"merger_acquisitions":[],"others":[]}}